are greater outside of the United States. Safe, reliable therapeutic agents with predictable activity against A. baumannii are presently nonexistent [17, 18] .
The need for an increased understanding of Acinetobacter infection pathogenesis, identification of virulence factors, and identification and testing of vaccine candidates and new antimicrobial targets is more pressing than ever [17, 18] . To identify genes important for growth and survival, we performed random mutagenesis on A. baumannii strain AB307-0294, which our research group has been studying as a model pathogen [19] . We hypothesized that screening this mutant pool for diminished or absent growth on plates made from human ascites would be an efficient means to identify such factors. As a result of this screen, the AB307-0294 mutant derivative AB307.27 was identified. AB307.27 contains its transposon insertion in pbpG, which encodes the putative low-molecular-mass penicillin-binding protein 7/8 (PBP-7/8) in Acinetobacter organisms. PBP-7/8 is a hydrolase/endopeptidase that hydrolyzes the D-ananyl--meso-2,6-diaminopimelyl cross-bridge bond in high-molecular-mass sacculi [20] . However, there was no discernible change in phenotype in an Escherichia coli PBP-7 mutant, as assessed by growth in laboratory medium [21] and by fluorescenceactivated cell sorting [22] . PBP-8 is a OmpT-mediated degradation product of PBP-7, and PBP-7 and PBP-8 have been shown in vitro to stabilize and enhance soluble lytic transglycosylase 70 [20, 23, 24] . PBP-7 is absent from gram-positive bacteria. The precise role of PBP-7/8 in gram-negative bacteria is unclear. It appears to be nonessential for normal cell elongation but has been implicated as an accessory enzyme that modulates cell morphology and in daughter cell separation [22, [25] [26] [27] . In this report, we describe a novel phenotype for PBP-7/8 in A. baumannii. This protein contributes to growth and survival of A. baumannii in human ascites in vitro and in vivo in rat soft-tissue infection and pneumonia models. These data lend new insight into the role of the low-molecular mass penicillin-binding proteins in clinically relevant environments.
MATERIALS AND METHODS

Bacterial strains and media.
A. baumannii strain 307-0294 (blood isolate; sequence type 15 and clonal group 1 [28] ) was isolated from a patient hospitalized at Erie County Medical Center (Buffalo, NY) in 1994. AB307-0294 was grown in Luria-Bertani medium, unless stated otherwise. The strain was maintained at Ϫ80°C in 50% Luria-Bertani broth and 50% glycerol. Ascites plates consisted of 80% human ascites (pH 7.3; ascites were not sterilized by filtration but were confirmed by culture as sterile) and 20% water. Two-hundred milliliters of water and 15 g of Bacto agar were autoclaved and cooled to 45°C, 800 mL of ascites and kanamycin (final concentration, 40 g/mL) were added, and plates were poured. For quantitative growth curves, the following were used: 100% human ascites, Luria-Bertani me-dium, and 100% human urine pooled from 4 healthy donors and filter sterilized before use. Strains were grown overnight in Luria-Bertani medium and diluted in the medium in which the growth curve was being determined, with starting titers ranging from 1 ϫ 10 4 to 1 ϫ 10 5 cfu/mL in a final volume of 2 mL. Incubations were at 37°C in a shaking water bath (120 rpm/min). Aliquots were removed at 0, 3, 6, and 24 h, and 10-fold serial dilutions in 1 ϫ PBS were performed to determine the bacterial concentration.
Transposon mutagenesis and screen for lack of growth on ascites plates. Electrocompetent cells were generated by growing AB307-0294 in Mueller-Hinton broth to an Å 600 of around 0.4. Fifteen milliliters of cells were washed once with 1 mL of ice-cold sterile mqH 2 O, followed by 2 washes with 10% ice-cold, sterile glycerol. After the last wash, cells were resuspended in 75 L and either used immediately or stored at -80°C before use. EZ-Tn5Ͻkan-2ϾTnp Transposome (60 ng in 3 L [Epicentre Biotechnologies]) was electroporated into 75 L of electrocompetent AB307-0294 (Bio-Rad Gene Pulser; 25 mF/2.5 kV/200 Ohm), using a 0.2-cm gap, in an ice-cold EP chamber (Bio-Rad Laboratories). Immediately after electroporation, cells were resuspended in SOC medium (Invitrogen) and grown at 37°C for 1 h. Aliquots were then plated on Mueller-Hinton plates supplemented with kanamycin (40 g/mL), and isolated colonies were purified on the same medium. These AB307-0294 mutants (presumably AB307-0294::Tn5Ͻkan-2Ͼ) were subsequently gridded onto ascites-kanamycin plates. AB307-0294 mutants that were confirmed to have minimal or no growth on the ascites-kanamycin plates were numbered consecutively and stored at Ϫ80°C.
DNA sequencing and analysis. The location of the transposon insertion in mutant derivatives of AB307-0294 was determined by chromosomal sequencing. Chromosomal DNA was prepared from the AB307-0294 mutants of interest by using a Qiagen Genomic-tip 100/G purification column (Qiagen). Cycle sequencing was performed off of the EZ-Tn5 ϽKan-2Ͼ Transposon (Epicentre Biotechnologies), using the BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems) in accordance with the protocol for sequencing genomic DNA. The KAN-2 FP-1 forward primer included in the transposon kit was used. Cycle sequencing was performed on 10-or 20-L reactions with the following PCR protocol: step 1, 96°C for 2 min; step 2, 96°C for 30 s, 50°C for 10 s, and 60°C for 4 min for 50 cycles; and step 3, 4°C, ramping 1°C/s. Cycle sequencing products were prepared for sequencing by use of the CleanSEQ (Agencourt) reaction cleanup reagent in accordance with the manufacturer's instructions. Sanger sequencing was performed with a 3130xl Genetic Analyzer DNA sequencer (Applied Biosystems). Sequence comparisons were performed via BLAST analysis of the nonredundant GenBank database.
Cloning of pbpG and construction of a complemented derivative of AB307.27 (PBP-7/8 negative). pbpG and 178 bases upstream and 150 bases downstream were cloned via PCRmediated amplification (forward primer: 5'-GCTGACGAGCTC-CAATGGAATGACAAAATTAGCAA-3'; reverse primer: 5'-CCT-AGTACCGGTCAATGGACCAAGTAAAAGATTCG-3'). Primers contained capped SacI and AgeI sites to facilitate ligation into the vector pNLAC1 (tetracycline and ampicillin resistant). The cloned pbpG was confirmed to be identical to that in strain AB307-0294 by bidirectional DNA sequencing. The pNLAC1:: pbpG construct was electroporated into AB307.27, generating the complemented strain AB307.27/pNLAC1::pbpG. pNLAC1 without insert was electroporated into AB307-0294 and AB307.27, generating the control strains AB307/pNLAC1 and AB307.27/pNLAC1. Structural analysis. A 3-dimensional homology model of PBP-7/8 (PBP-78A) was created using the automated first approach mode in SWISS-MODEL [29 -31] . The sequence of AB307-0294 PBP-7/8 was entered in FASTA format and submitted to the SWISS-MODEL server (available at: http: // swissmodel.expasy.org/workspace/index.php?funcϭmodelling_ simple1&useridϭUSERID&tokenϭTOKEN). A BLAST value E-limit for choosing the best template was set to 0.00001. The model PBP-7/8 was returned in Protein Data Bank format. The PBP-7/8 model, the best template, and other templates with identity scores of Ͼ25% were superimposed using the secondary structure matching module in Coot [32] . A primary sequence alignment for all templates was performed with ClustalW2 (available at: http://www.ebi.ac.uk/Tools/clustalw2/index .html), using the default settings [33] . The superimposed structures were examined in 3 dimensions, using the graphical display in Coot [34] . The sequence alignment was adjusted by hand to correspond to the overlap of residues in 3-dimensional space.
Rat soft-tissue infection model. The rat pneumonia and soft-tissue infection model animal studies were reviewed and approved by the University at Buffalo and Veterans Administration Institutional Animal Care Committee. An established Long-Evans rat soft-tissue infection model was used as reported elsewhere [35] .
Rat pneumonia model. An established Long-Evans rat model for studying pulmonary damage was used as reported elsewhere [36, 37] . Serum bactericidal assay. Complement-mediated bactericidal assays were performed as previously described [38] .
Transmission electron microscopy (TEM). TEM was performed as described elsewhere [39] .
Statistical analyses. Data are presented as mean values (ϮSEM). P values of .05/n (where n is the number of comparisons) are considered statistically significant, based on use of Bonferroni correction for multiple comparisons, and P values of Ͼ.05/n but Ͻ.05 are considered as representing a trend. To normalize in vitro and in vivo data, log 10 -transformed values were used. The area under each curve was calculated, and the areas were compared using 2-tailed unpaired t tests (Prism 4 for MacIntosh [GraphPad Software]).
RESULTS
Identification of AB307-0294 PBP-7/8. To identify factors in
Acinetobacter organisms that are necessary for growth and survival in human infection, we used an experimental approach that was a modification of the method we previously used to identify virulence factors in extraintestinal pathogenic E. coli [40, 41] . First, random transposon mutagenesis was performed, and transposon mutants were selected on plates with nutrient-rich laboratory medium (i.e., Mueller-Hinton agar). Next, mutants were gridded onto ascites plates, which consisted of 80% human ascites (fluid that accumulates in the peritoneal cavity in pathologic states) and agar. Ascites plates are an ex vivo modified minimal medium and in essence are roughly reflective of inflammatory extracellular fluid, a common environment for extracellular bacterial pathogens such as Acinetobacter organisms. This screen resulted in the identification of AB307.27. Quantitative growth curves confirmed that AB307.27 was significantly killed in ascites (P Ͻ .001), but its growth in laboratory medium (i.e., Luria-Bertani broth) was similar to growth of its parent AB307-0294 (P ϭ .13) ( figure 1A ). Chromosomal sequencing, priming off of the EZ-Tn5 ϽKan-2Ͼ transposon, was performed on DNA purified from AB307.27. The transposon insertion within AB307.27 was in pbpG (between nucleotides 462 and 463), which encoded a putative D-alanyl-D-alanine endopeptidase or PBP-7/8. The complete sequence of AB307-0294 PBP-7/8 and its surrounding genes was determined (Genbank accession number EU676123). The open reading frame of pbpG contained 1023 nucleotides, which encoded a protein of 340 amino acids with a predicted molecular weight of 35,949 Da. Because the direction of transcription for a putative threonine synthase, encoded by the open reading frame 3' to pbpG, was in the opposite direction, the transposon insertion in pbpG should not have a polar effect. To confirm this, quantitative growth curves were performed in ascites with the constructs AB307-0294/pNLAC1 (a wild-type parent containing the cloning vector without an insert), AB307.27/pNLAC1 (a PBP-7/8 mutant derivative of AB307-0294 containing the cloning vector without an insert), and AB307.27/pNLAC1::pbpG (a PBP-7/8 mutant derivative containing cloned pbpG). Growth of the wild-type parent AB307-0294/pNLAC1 was similar to growth of the complemented mutant AB307.27/pNLAC1::pbpG (P ϭ .17), confirming that inactivation of PBP-7/8 was responsible for decreased growth in ascites. As expected, the noncomplemented strain AB307.27/pNLAC1 demonstrated a significant decrease in survival in ascites, compared with AB307-0294/pNLAC1 (P Ͻ .001) and AB307.27/pNLAC1::pbpG (P Ͻ .001) ( figure 1B) .
In silico analysis of AB307-0294 PBP-7/8. The SWISS-MODEL server created a model covering residues 92-332 of PBP-7/8, resulting in a final E-score of 3.56e-16. PBP-5 from E. coli (Protein Data Bank code 1nj4) was chosen as the best template (27% identity to PBP-7/8) [42] . Other homologous proteins with crystal structures available and Ͼ25% identity with PBP-7/8 were PBP-4 from Staphylococcus aureus (Protein Data Bank code 1tvf) (Rajashankar et al., unpublished data), PBP-3 from Streptococcus pneumoniae (Protein Data Bank code 1xp4) [43] , and DD-transpeptidase from Streptomyces strain K15 (Pro-tein Data Bank code 1skf) [44] . Surprisingly, even with the low levels of sequence identity, the active site residue motifs SXXK, SXN, and KTG were completely conserved (figure 2). The superposition of all structures placed the active site residues within a root mean square deviation of 1.5 Å from their positions in each structure. Although the sequences surrounding the active site residues were varied, there was strict conservation of the secondary structural elements creating the active site scaffold (figure 2). Next, the DNA/predicted protein homology of AB307-0294 PBP-7/8 was compared with various homologues/orthologues (table 1, which appears only in the electronic edition of the Journal). Finally, a promoter prediction analysis was performed on the 5' DNA sequence to the predicted transcriptional start site of pbpG (BPROM [SoftBerry]; available at: http://www.softberry .com/berry.phtml?topicϭbprom&groupϭprograms&subgroup ϭgfindb). A putative promoter, whose transcription is predicted to be directed by the 70 factor, was identified.
AB307 .27 (PBP-7/8 negative) has an abnormal morphology. The cell morphology of AB307.27 (PBP-7/8) was assessed via TEM. When grown in logarithmic phase in Luria-Bertani medium, more coccobacillary forms of AB307.27 (PBP-7/8 neg-ative) were observed, compared with its wild-type parent AB307-0294; however, both coccobacillary and bacillary forms were seen with each strain ( figure 3 ). This finding suggests that AB307.27 may possess an abnormal peptidoglycan and suggests that, in Acinetobacter organisms, PBP-7/8 may play a more critical role in modulating cell morphology than has been described for other species [22] . AB307.27 (PBP-7/8 negative) is killed in the rat soft-tissue infection model. An in vivo validation of our in vitro findings was needed to confirm that PBP-7/8 was a factor that contributed to Acinetobacter infection. Initially, we compared the growth/survival of AB307-0294 (wild-type) and its isogenic derivative AB307.27 (PBP-7/8 negative) in a rat model of softtissue infection. A major advantage of this infection model is that multiple samples can be obtained over time from each animal, making it time-and cost-efficient for initial assessment of strains in vivo. Furthermore, it is clinically relevant given that A. baumannii has been increasingly recognized as a cause a variety of soft-tissue infections [10, 12] . Compared with AB307-0294, AB307.27 demonstrated a significant decrease in survival in this Figure 3 . Transmission electron microscopy was performed on AB307-0294 (wild-type) and AB307.27 (penicillin-binding protein 7/8 negative) as described elsewhere [39] . Cells were grown in Luria-Bertani medium in logarithmic phase. A and C, AB307-0294 (10,000ϫ and 20,000ϫ original magnification, respectively); B and D, AB307.27 (10,000ϫ and 20,000ϫ original magnification, respectively). AB307.27 demonstrates an increase in susceptibility to complement-mediated bactericidal activity. The innate re-sponse is instrumental in determining whether extracellular bacterial pathogens such as Acinetobacter organisms are successfully cleared or establish an infection. The complement system is a critical component of the host's innate immune system. Therefore, we assessed whether AB307.27 had increased susceptibility to complement-mediated bactericidal activity, compared with its parent, AB307-0294. Compared with AB307-0294, AB307.27 demonstrated a significant decrease in survival in 90% human serum (P Ͻ .001) ( figure 6 ). These data support the concept that complement-mediated bactericidal activity in vivo is at least one mechanism responsible for the clearance of AB307.27 in the rat soft-tissue infection and pneumonia models. AB307-0294 (wild-type) . The growth of AB307-0294 and AB307.27 in human urine was assessed because the urinary tract is another site that Acinetobacter organisms commonly infect. However, in urine, complement levels are low and anticomplement activity may be present [45, 46] . The growth of AB307-0294 and AB307.27 was similar in human urine (P ϭ .07) ( figure 7) . These data demonstrate that PBP-7/8 is not important for the growth/survival of AB307-0294 in human urine.
Growth of AB307.27 (PBP-7/8 negative) in human urine is similar to that of
DISCUSSION
To our knowledge, this is the first report to describe a role for PBP-7/8 in the pathogenesis of infection. We demonstrated that the PBP-7/8 -deficient mutant AB307.27, an isogenic derivative of the wild-type A. baumannii strain AB307-0294, was killed in human ascites ( figure 1 ). Next, we demonstrated that AB307.27 was also killed in vivo in rat soft-tissue infection and pneumonia models (figures 4 and 5), both important types of Acinetobacter infection. We then demonstrated that AB307.27 was killed in 90% human serum in vitro ( figure 6 ). TEM demonstrated more coccobacillary forms of AB307.27, compared with AB307-0294 ( figure 3 ), suggesting a possible modulation in the peptidoglycan, which may affect susceptibility to host defense factors. Finally, the growth of AB307.27 was similar to AB307-0294 in human urine ( figure 7) , an environment in which complement levels are low and anticomplement activity may be present [45, 46] . Taken together, these results demonstrate that PBP-7/8 contributes to the pathogenesis of A. baumannii in the rat softtissue infection and pneumonia models. Furthermore, PBP-7/8 either directly or indirectly contributes to the resistance of AB307-0294 to complement-mediated bactericidal activity.
PBPs and their role in peptidoglycan synthesis have been extensively reviewed [27, 47, 48] . In brief, bacterial peptidoglycan consists of cross-linked N-acetylglucosamine and N-acetylmu-ramic acid glycan chains. It is a critical cell structure that provides the bacterium shape and is instrumental in resisting various physical forces [27, 47, 49] . PBPs have been classified as having a high or low molecular mass. High-molecular-mass PBPs enable peptidoglycan polymerization and insertion into the preexisiting cell wall [27, 47] . low-molecular-mass PBPs contribute to cell separation and peptidoglycan remodeling [22, 27, 49] . The low-molecular-mass PBPs have been less well studied than the high-molecular-mass class A and class B enzymes [47, 48] . However, in limited studies involving E. coli, lowmolecular-mass PBPs, including PBP-7/8, have in general been shown not to be essential when grown in Luria-Bertani medium [21, 22, 25, 26] . PBP-7/8 has been postulated to play a role in cell wall remodeling [20, 50] . In contrast to AB307-0294, in Salmonella organisms the expression of PBP-7 is under the direction of the S factor and is induced in carbon-starved medium (starvation-stress response), but a PBP-7-negative mutant was equally virulent as its wild-type parent after oral gavage in a BALB/c mouse sepsis model [50] . Therefore, the dramatic phenotype observed with AB307.27 both in human serum and ascites in vitro and in rat pneumonia and soft-tissue infection models was novel and surprising. We have established that at least 1 mechanism for this phenotype is an increase in susceptibility to complement-mediated bactericidal activity ( figure 6 ). It remains possible that PBP-7/8 directly or indirectly contributes to the resistance of AB307-0294 to the bactericidal activity mediated by professional phagocytes or antimicrobial peptides, but these possibilities were not directly assessed in this report. The increase in coccobacillary forms of AB307.27, compared with AB307-0294, suggests that its peptidoglycan may be altered. However, further quantitative definition of the probable abnormalities in the peptidoglycan in AB307.27 via flow cytometry and/or biochemical methods are required to confirm that the peptidoglycan is truly abnormal in AB307.27 (PBP-7/8 negative) Figure 6 . Effect of 90% normal human serum on the viability of the Acinetobacter baumannii strain AB307-0294 (wild-type [wt]) and its isogenic derivative AB307.27 (penicillin-binding protein 7/8 negative). Assays were performed as described elsewhere [38] . All strains were also assessed in the presence of 90% heat-inactivated (at 56°C for 30 min) normal human serum, and their growth was similar; therefore these data are not shown. Bacterial titers were determined at 0, 1, 2, and 3 h. Survival of AB307.27 (n ϭ 4) was significantly decreased, compared with AB307-0294 (n ϭ 4) (*P Ͻ .001, by a 2-tailed unpaired t test). and, if so, to define the nature of the change. Furthermore, whether this is a direct or an indirect result of the loss of PBP-7/8 is unresolved. A direct effect, resulting in an alteration in the structure of peptidoglycan due to the loss of PBP-7/8, would seem most likely. However, because PBP-7/8 is a hydrolase, one might predict that overexpression, not a lack of expression, would increase the susceptibility of the bacterium to complement-mediated bactericidal activity. An indirect effect on other PBP or glycolases (e.g., soluble lytic transglycosylase 70), which in turn affects the peptidoglycan structure, or an indirect effect independent of peptidoglycan remain possibilities. Future studies that assess binding of various proteins in the complement system will generate new insights on the mechanism by which PBP-7/8 contributes to complement resistance.
Selection for transposon mutant derivatives of AB307-0294 on laboratory medium and then screening for essentiality on ascites plates were critical for the efficiency of our approach. This simple innovation enabled us able to identify, in one step, genes that are both essential and expressed in vivo. The strength of this approach is that it is unbiased and highly efficient. We did not select the targets but allowed the genetic screen, designed to identify the phenotype of in vivo essentially, to dictate the choices. Furthermore, although we did not identify genes that are essential for growth in laboratory medium, we were able to identify those that are essential for growth/survival in ascites but not Mueller-Hinton medium, a more interesting mutant set. Subsequent identification of the gene into which the transposon inserted in mutants of interest by chromosomal sequencing and an in vivo assessment in the soft-tissue infection model resulted in a relatively efficient approach for identifying previously unrecognized and unknown virulence factors, as well as potential drug targets.
In summary, we have established that PBP-7/8 is critical for the survival of A. baumannii strain AB307-0294 in the rat softtissue infection and pneumonia models. Furthermore, PBP-7/8 either directly or indirectly contributes to the resistance of AB307-0294 to complement-mediated bactericidal activity. An understanding of how PBP-7/8 contributes to serum resistance will lend insight into the role of this low-molecular-mass PBP whose function is poorly understood.
